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SYSTEMATIC REVIEW AND META-ANALYSIS
Impact of Circadian Blood Pressure Pattern 
on Silent Cerebral Small Vessel Disease: A 
Systematic Review and Meta- Analysis
Anthipa Chokesuwattanaskul , MD; Wisit Cheungpasitporn, MD; Charat Thongprayoon, MD;  
Saraschandra Vallabhajosyula, MD; Tarun Bathini, MD; Michael A. Mao, MD; Liam D. Cato, MB ChB;  
Ronpichai Chokesuwattanaskul , MD
BACKGROUND: Abnormal circadian blood pressure (BP) variations during sleep, specifically the non- dipping (<10% fall in noc-
turnal BP) and reverse- dipping patterns (rise in nocturnal BP), have been associated with an increased risk of cardiovascular 
events and target organ damage. However, the relationship between abnormal sleep BP variations and cerebral small vessel 
disease markers is poorly established. This study aims to assess the association between non- dipping and reverse- dipping 
BP patterns with markers of silent cerebral small vessel disease.
METHODS AND RESULTS: MEDLINE, Embase, and Cochrane Databases were searched from inception through November 2019. 
Studies that reported the odds ratios (ORs) for cerebral small vessel disease markers in patients with non- dipping or reverse- 
dipping BP patterns were included. Effect estimates from the individual studies were extracted and combined using the 
random- effect, generic inverse variance method of DerSimonian and Laird. Twelve observational studies composed of 3497 
patients were included in this analysis. The reverse- dipping compared with normal dipping BP pattern was associated with a 
higher prevalence of white matter hyperintensity with a pooled adjusted OR of 2.00 (95% CI, 1.13–2.37; I2=36%). Non- dipping 
BP pattern compared with normal dipping BP pattern was associated with higher prevalence of white matter hyperintensity 
and asymptomatic lacunar infarction, with pooled ORs of 1.38 (95% CI, 0.95–2.02; I2=52%) and 2.33 (95% CI, 1.30–4.18; 
I2=73%), respectively. Limiting to only studies with confounder- adjusted analysis resulted in a pooled OR of 1.38 (95% CI, 
0.95–2.02; I2=52%) for white matter hyperintensity and 1.44 (95% CI, 0.97–2.13; I2=0%) for asymptomatic lacunar infarction.
CONCLUSIONS: The non- dipping and reverse- dipping BP patterns are associated with neuroimaging cerebral small vessel 
disease markers.
Key Words: blood pressure variability ■ circadian ■ meta-analysis ■ microbleed ■ white matter
Circadian rhythm plays an important role in the governance and maintenance of homeostasis in the human body.1 The normal circadian blood 
pressure pattern is characterized by a mild decrease 
in blood pressure during sleep that reaches its trough 
around midnight when the deep sleep stages are 
most abundant (nocturnal dip), with a subsequent 
gradual rise towards the end of sleep (morning surge). 
However, in some individuals during sleep, the noc-
turnal dip is blunted or reversed. This results in the 
absence of a nocturnal dip or even a slight increase 
in blood pressure, termed “non- dipper” and “reverse- 
dipper”, respectively.2,3
Studies have found that these abnormal blood 
pressure patterns are linked to an increased risk for 
cardiovascular events and target organ damage in 
both normotensive and hypertensive individuals.4–11 
Moreover, better control of sleep blood pressures has 
been shown to exert greater protection against stroke 
and cardiovascular events in many studies.12,13 The 
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insurmountable evidence linking these 2 abnormal 
blood pressure patterns to target organ damages and 
cardiovascular events lead us to explore its association 
to presymptomatic markers of cerebrovascular disease, 
the neuroimaging markers of cerebral small vessel dis-
ease (CSVD).
Silent findings of CSVD on neuroimaging studies, 
such as white matter hyperintensities (WMH), asymp-
tomatic lacunar infarction (ALI), cerebral microbleeds 
(CMBs), and enlarged perivascular spaces (PVS), have 
recently emerged as important surrogate markers for 
cerebrovascular disease.14 Elevated blood pressures 
are one of the main risk factors for CSVD, and better 
control of blood pressure has been shown to decrease 
WMH progression.15–17 However, the relationship be-
tween abnormal circadian blood pressure variations 
and CSVD neuroimaging markers has not been well 
established.
This study investigates the association between 
abnormal circadian blood pressure variations, specif-
ically the non- dipping and reverse- dipping patterns, 
and silent CSVD neuroimaging markers by performing 
a systematic review and meta- analysis of the relevant 
published literature.
METHODS
The protocol for this meta- analysis is registered with 
PROSPERO (International Prospective Register of 
Systematic Reviews; no. CRD42020147729). The 
data for this systematic review and all potentially eli-
gible studies are publicly available through the Open 
Science Framework (URL: https://osf.io/gf8pr/).
Search Strategy and Literature Review
A systematic literature search of EMBASE (1988 to 
November 2019), Ovid MEDLINE (1946 to November 
2019), and the Cochrane Database of Systematic 
Reviews (database inception to November 2019) was 
performed to assess the association of abnormal cir-
cadian sleep blood pressure variations, specifically the 
non- dipping and reverse- dipping blood pressure pat-
terns, on CSVD neuroimaging markers consisting of 
WMH, ALI, CMBs, and enlarged PVS. The non- dipping 
blood pressure pattern refers to a nocturnal blood 
pressure fall of <10% from the awake blood pressures, 
and the reverse- dipping blood pressure pattern refers 
to a rise in nocturnal blood pressures.18 The systematic 
literature review was undertaken independently by 2 
investigators (A.C. and R.C.) using a search approach 
that incorporated the terms “dipping” OR “non- dipping” 
OR “dipper” OR “non- dipper” OR “reverse- dipping” 
OR “reverse- dipper” OR “circadian blood pressure” 
OR “nocturnal blood pressure”, “night- time blood pres-
sure”, “ambulatory blood pressure”, “ambulatory blood 
pressure monitoring” AND “silent cerebrovascular dis-
ease” OR “silent stroke” OR “silent ischemic stroke” 
OR “white matter hyperintensity” OR “lacunar infarct” 
OR “cerebral microbleed” OR “brain microbleed” OR 
“small vessel disease” OR “cerebrovascular disease” 
OR “silent cerebral infarct” OR “white matter change” 
OR “perivascular space”. The search strategy used for 
each database is provided in Data S1. No language 
limitation was applied. A manual search for conceivably 
relevant studies using the references of included arti-
cles was also performed. This study was conducted by 
the Preferred Reporting Items for Systematic Reviews 
and Meta- Analysis statement,19 as provided in Data S1.
Selection Criteria
To be included in the meta- analysis, studies were re-
quired to meet the following criteria: (1) observational 
studies including cohort, case- control, or cross- 
sectional studies (2) reported the association of non- 
dipping or reverse- dipping blood pressure patterns on 
WMH, ALI, CMBs, or enlarged PVS, (3) an outcome 
definition was provided, (4) and reported odds ratios 
(OR) of any CSVD neuroimaging markers. Review ar-
ticles and case reports were excluded from this meta- 
analysis. Retrieved articles were individually reviewed 
CLINICAL PERSPECTIVE
What Is New?
• This systematic review and meta-analysis of 
3497 patients from 12 studies demonstrated an 
association between abnormal circadian blood 
pressure pattern, reverse-dipping and non-
dipping nighttime blood pressure patterns, and 
prevalent cerebral small vessel disease.
What Are the Clinical Implications?
• These results further support the concerns 
about the abnormal circadian blood pressure 
pattern and 24-hour blood pressure control on 
target organ damages.
• This study demonstrates the usefulness of 
neuroimaging markers of silent cerebral small 
vessel disease as a presymptomatic marker of 
cerebrovascular disease.
Nonstandard Abbreviation and Acronyms
ALI asymptomatic lacunar infarction
CMB cerebral microbleed
CSVD cerebral small vessel disease
PVS perivascular space
WMH white matter hyperintensity
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for eligibility by the 2 investigators (A.B. and R.C.). 
Discrepancies were addressed and solved by mutual 
agreement. Inclusion was not limited by the size of the 
study. Newcastle- Ottawa quality assessment scale 
was used to appraise the quality of the included ob-
servational studies.20
Data Abstraction
Characteristics of the study including first author, study 
location, publication year, study design, patient demo-
graphic data, CSVD outcome definition, exposure and 
measurement of exposure, follow up time, and con-
founder adjustments were retrieved. ORs reported in 
each study were extracted.
Statistical Analysis
All statistical analyses were performed using the 
Comprehensive Meta- Analysis version 3 software 
(Eaglewood, NJ, USA). The pooled ORs of silent CSVD 
neuroimaging markers in patients with non- dipping or 
reverse- dipping blood pressure patterns were calcu-
lated using a generic inverse method of DerSimonian 
Figure 1. Outline of our selection process.
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and Laird.21 A random- effects model was used, given 
the high likelihood of between study variance. Cochran 
Q- test, which is supplemented by I2 statistic, was used 
to evaluate statistical heterogeneity. The I2 statistic 
quantifies the proportion of total variation across stud-
ies that is because of true heterogeneity rather than 
chance. A value of I2 of 0% to 25% denotes trivial het-
erogeneity, 25% to ≤50% denotes low heterogeneity, 
50% to ≤75% denotes moderate heterogeneity, and 
>75% represents high heterogeneity.22
RESULTS
We identified a total of 1334 potentially eligible studies 
from our search strategy. After title and abstract re-
view, 20 studies were excluded because they were du-
plicates and 1281 studies were excluded because they 
did not fulfill the inclusion criteria based on the type 
of article, study design, study population, or outcome 
of interest. Thirty- three articles were left for full- length 
review. Nineteen articles were subsequently excluded 
because they did not report the odds ratios for neuro-
imaging CSVD findings in relationship to non- dipping 
or reverse- dipping blood pressure pattern. Another 2 
studies were excluded because they were not obser-
vational studies. Ultimately, 12 cross- sectional studies 
comprising 3497 individuals were enrolled.23–34 The 
literature retrieval, review, and selection process are 
demonstrated in Figure  1. The characteristics of the 
included studies are presented in Table.
Association of a Blood Pressure Reverse- 
Dipping Pattern With CSVD Neuroimaging 
Features
There was a significant association between the noctur-
nal blood pressure reverse- dipping pattern and WMH 
with a pooled adjusted OR of 2.00 (95% CI, 1.13–2.37; 
I2=36%), when compared with patients with normal 
nocturnal dip (Figure 2A).24,28,30 Sensitivity analysis was 
performed including only clinic- based cross- sectional 
studies and demonstrated a significant association 
between the nocturnal blood pressure reverse- dipping 
pattern and WMH with a pooled adjusted OR of 3.16 
(95% CI, 1.44–6.93; I2=0%).24,28
Two studies assessed the association of the reverse- 
dipping pattern and ALI compared with normal dipping 
pattern. The pooled adjusted OR was 2.77 (95% CI, 0.68–
11.34; I2=43%) for reverse- dipping pattern (Figure 2B).24,28
Association of Blood Pressure  
Non- Dipping Pattern With CSVD 
Neuroimaging Features
There was a significant association between the 
non- dipping blood pressure pattern and WMH with S
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a pooled OR of 1.51 (95% CI, 1.06–2.14, I2=55%), 
when compared with patients with a normal noctur-
nal dip (Figure 3A).24,28,30,33,34 Sensitivity analysis was 
performed including only clinic- based cross- sectional 
studies and demonstrated a significant association 
between the non- dipping blood pressure pattern and 
WMH with a pooled adjusted OR of 1.99 (95% CI, 
1.29–3.05; I2=0%).24,28,33 Meta- analysis limited to stud-
ies with confounder- adjusted analysis was performed. 
The adjusted pooled OR for WMH was 1.38 (95% CI, 
0.95–2.02; I2=52%) among patients with non- dipping 
nocturnal blood pressure pattern (Figure S1).24,28,30,34
An analysis of all studies assessing the associ-
ation between ALI and non- dipping blood pressure 
pattern compared with normal dipping blood pres-
sure pattern revealed a significant association with 
a pooled OR of 2.33 (95% CI, 1.30–4.18; I2=73%) 
(Figure  3B).23,24,27–29,34 Sensitivity analysis was per-
formed including only clinic- based cross- sectional 
studies and demonstrated a significant association 
between the non- dipping blood pressure pattern 
and ALI with a pooled adjusted OR of 2.82 (95% CI, 
1.34–5.95; I2=74%).23,24,27–29 However, when the anal-
ysis was limited to only confounder- adjusted studies, 
the association was not statistically significant, with 
a pooled adjusted OR of 1.44 (95% CI, 0.97–2.13; 
I2=0%) (Figure S2).24,28,34
There was no significant association between noc-
turnal blood pressure non- dipping pattern and CMBs 
when compared with normal nocturnal dipping pat-
tern in all included studies. The pooled OR was 1.17 
(95% CI, 0.82–1.67; I2=0%) (Figure  3C)25,26,31,32 and 
the pooled adjusted OR was 1.14 (95% CI, 0.79–1.64; 
I2=0%) (Figure S3).25,26,31
Data on the association between abnormal cir-
cadian blood pressure variations and enlarged PVS 
were limited and thus a meta- analysis could not be 
performed.
Evaluation for Publication Bias
Since tests for funnel plot asymmetry should be used 
only when there are at least 10 study groups, a fun-
nel plot was not drawn because of the limited num-
ber of studies.35 Egger regression asymmetry test 
Figure  2. Forest plot of the association between reverse- dipping pattern and silent cerebral small vessel disease 
neuroimaging features. 
A, Forest plots of included studies assessing the association between reverse- dipping pattern and white matter hyperintensity. B, 
Forest plots of the included studies assessing the association between reverse- dipping pattern and asymptomatic lacunar infarct. A 
diamond data marker depicts the overall rate from included studies (square data markers) and 95% CI. WMH indicates white matter 
hypersensitivity.
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Figure 3. Forest plot of the association between non- dipping pattern and silent cerebral small vessel disease neuroimaging 
features. 
A, Forest plots of the included studies assessing the association between non- dipping pattern and white matter hyperintensity. B, 
Forest plots of the included studies assessing association between non- dipping pattern and asymptomatic lacunar infarction . C, 
Forest plots of the included studies assessing association between non- dipping pattern and cerebral microbleeds. A diamond data 
marker depicts the overall rate from included studies (square data markers) and 95% CI. CMB indicates cerebral microbleeds; and 
WMH, white matter hypersensitivity. 
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was performed and showed no publication bias with 
P<0.05 for all analyses.
DISCUSSION
Our study demonstrated a significant association be-
tween a reverse- dipping blood pressure pattern and a 
higher prevalence of WMH, but not ALI. A significant 
unadjusted association was also found between a 
non- dipping blood pressure pattern and an increased 
prevalence of both WMH and ALI. However, when lim-
iting the analysis to only confounder- adjusted studies 
(4 studies for WMH and 3 studies for ALI), the results 
were no longer statistically significant. We did not find 
an association between a non- dipping blood pressure 
pattern and CMBs.
Hypertension is known to cause damage to both 
large and small vessels leading to target organ dam-
ages, most importantly the heart, brain, and kid-
neys.36,37 In hypertensive cerebral small vessel disease, 
researchers found that hypertension primarily causes 
endothelial dysfunction leading to subsequent blood- 
brain barrier dysfunction, formation of microaneu-
rysms, decreased cerebrovascular reactivity, cerebral 
hypoperfusion, and neuroinflammation.16,38–41 These 
pathological processes in the brain parenchyma can 
produce either “silent” findings on neuroimaging stud-
ies or symptoms such as strokes.
The circadian rhythm is essential for the regulation 
and maintenance of normal physiologic functions in 
the body. The circadian control of the cardiovascular 
system is most evident with the diurnal blood pressure 
pattern, characterized by a rise in blood pressure in 
the morning before awakening and a decrease while 
sleeping in the night.42,43 This control is achieved 
through a synergy of several processes, including 
neurohormonal factors, vascular tone, the autonomic 
nervous system, and renal system.1,5,42,44 Abnormal 
function of these processes or certain environmental 
changes could lead to disruption of this normal circa-
dian blood pressure pattern through either increased 
cardiac output or systemic vascular resistance during 
sleep. Common diseases associated with this dis-
ruption include diabetes mellitus, neurodegenerative 
diseases with autonomic dysfunction, chronic kidney 
disease, obstructive sleep apnea, and most secondary 
causes of hypertension.2,5,45
An abnormal circadian blood pressure pattern, 
consisting of non- dipping or reverse- dipping, has 
been shown in several studies to increase the risk 
of cardiovascular disease. Studies have found an in-
creased risk of myocardial infarction, peripheral artery 
disease, increased prevalence of vascular disease 
markers (eg, carotid plaque), and other cardiovascu-
lar events in individuals with non- dipping or reverse- 
dipping patterns.4–7,9,10,46,47 Karadag et al showed that 
a non- dipping blood pressure pattern was associated 
with a higher risk of microalbuminuria and hypertensive 
retinopathy in hypertensive patients.8 Another study by 
Yan et al found a significantly increased risk of lacunar 
infarction in reverse- dipping compared with non- and 
normal- dipping hypertensive patients.11
The pathophysiologic mechanism of non- dipping 
and reverse- dipping blood pressure pattern on vessels 
remains unclear. Some have proposed that the non- 
dipping and the reverse- dipping blood pressure pat-
terns result in a higher 24- hour mean blood pressure 
level, thereby imposing a greater overall pressure load 
and shear stress to vessels, resulting in accelerated 
atherosclerotic disease.26,30,34 This hypothesis is sup-
ported by studies that have demonstrated that reverse- 
dippers are more affected than non- dippers.11,24,28,30 
Our findings provide further evidence revealing an as-
sociation between abnormal circadian blood pressure 
pattern and silent CSVD markers, and with reverse- 
dippers having a more significant risk compared with 
non- dippers. However, it remains to be elucidated if 
other mechanisms are involved in the process.
The neuroimaging features of silent CSVD, such 
as WMH, ALI, CMBs, and enlarged PVS, have re-
cently been widely adopted as markers of small ves-
sel cerebrovascular disease. Its main advantage is 
the ability to detect disease in its presymptomatic 
stage.14,48 Discrepancies between each neuroimag-
ing markers and their clinical importance have been 
reported. This may be largely because of the sensitiv-
ity of each marker on magnetic resonance imaging, 
the different techniques used to identify each marker, 
and the slightly different pathogenic processes for 
each marker.49 This discrepancy was also evident in 
our study. In addition, it is also worth noting that the 
magnetic resonance imaging used in most of the in-
cluded studies in this meta- analysis was performed 
using 1.5  T magnetic resonance imaging, which is 
less sensitive for pathological changes than the 3 T 
magnetic resonance imaging used in most current 
research studies. Moreover, detection of CMBs in 
the included studies was done on gradient echo 
(GRE) sequence rather than the currently recom-
mended susceptibility- weighted imaging, which of-
fers more diagnostic sensitivity.50 Hence, because of 
the known technical limitations with the neuroimag-
ing techniques used in these prior studies, the actual 
prevalence of WMH, ALI, and CMBs may be higher 
and the association more prominent if current and 
more sensitive neuroimaging techniques were used.
Interestingly, restoration of the normal physio-
logic blood pressure pattern by decreasing nighttime 
blood pressure has been explored in several stud-
ies.51,52 The MAPEC (Spanish hypertensive cohort 
study [PMID: 20854139]) study, which aimed to com-
pare bedtime long- acting anti- hypertensive medication 
D
ow
nloaded from
 http://ahajournals.org by on June 11, 2020
J Am Heart Assoc. 2020;9:e016299. DOI: 10.1161/JAHA.119.016299 9
Chokesuwattanaskul et al Circadian Blood Pressure Pattern and CSVD
administration (chronotherapy) to conventional morn-
ing time therapy, reported better control of 24- hour 
blood pressure, lower prevalence of non- dipper, and 
decreased total and major cardiovascular events in 
the bedtime treatment group.13 Another cohort study 
in both normotensive and hypertensive patients found 
that the decrease in nighttime systolic blood pressure 
was the most significant predictor for cardiovascular 
event- free survival after 5 years of follow- up, regardless 
of awake or office systolic blood pressure.4 Finally, a 
meta- analysis of 9 cohort studies in hypertensive pa-
tients found that an increased nighttime systolic blood 
pressure was the best predictor of adverse cardiovas-
cular events.53 These studies highlight the importance 
of nighttime blood pressure in the pathogenesis of vas-
cular diseases.
This study has several limitations. First, a causal re-
lationship between abnormal circadian blood pressure 
patterns and CSVD cannot be established because 
of the cross- sectional design of the studies. Second, 
the number of studies is relatively limited. There are 
even fewer studies that explored the prevalence of 
CMBs in reverse- dippers,31 and there are no avail-
able studies that explored the association of enlarged 
PVS with abnormal circadian blood pressure patterns. 
Consequently, the number of available studies explor-
ing the association with certain CSVD neuroimaging 
findings may be too few to achieve a statistically signif-
icant result. Third, most studies used a single 24- hour 
ambulatory blood pressure measurement, which could 
not demonstrate the reproducibility or persistence of 
the abnormal circadian blood pressure pattern in 
each individual. Finally, the classification of nocturnal 
blood pressure decrease into dipping, non- dipping, 
and reverse- dipping groups rather than analyzing the 
quantitative measurement of the changes in nocturnal 
blood pressure further limits the extent of the analysis.
CONCLUSIONS
The non- dipping and reverse- dipping blood pressure 
patterns are associated with neuroimaging markers of 
CSVD. However, whether restoration of a normal phys-
iologic nocturnal blood pressure pattern would prevent 
further progression of CSVD is unknown. Future stud-
ies with a longitudinal design assessing the treatment 
effect of chronotherapy on CSVD neuroimaging fea-
tures are needed.
ARTICLE INFORMATION
Received February 27, 2020; accepted April 30, 2020.
Affiliations
From the Division of Neurology (A.C.) and Department of Medicine (R.C.), 
Faculty of Medicine, Chulalongkorn University and King Chulalongkorn 
Memorial Hospital, Bangkok, Thailand; King Chulalongkorn Memorial 
Hospital, Thai Red Cross Society, Bangkok, Thailand (A.C., R.C.); Department 
of Medicine, University of Mississippi Medical Center, Jackson, MS (W.C.); 
Division of Nephrology, Departments of Medicine (C.T.) and Cardiovascular 
Medicine (S.V.), Mayo Clinic, Rochester, MN; Department of Internal Medicine, 
University of Arizona, Tucson, AZ (T.B.); Department of Internal Medicine, 
Mayo Clinic, Jacksonville, FL (M.A.M.); University Hospitals Birmingham NHS 
Foundation Trust, Birmingham, United Kingdom (L.D.C.).
Acknowledgments
All authors had access to the data and played significant roles in the writing 
and review of the article. All authors confirmed they have contributed to the 
intellectual content of this paper and approved the final article.
Sources of Funding
None.
Disclosures
None.
Supplementary Materials
Data S1
Figures S1–S3
References 24–26, 28, 30–31, and 34
REFERENCES
 1. Smolensky MH, Hermida RC, Portaluppi F. Circadian mechanisms of 
24- hour blood pressure regulation and patterning. Sleep Med Rev. 
2017;33:4–16.
 2. Hassler C, Burnier M. Circadian variations in blood pressure: implica-
tions for chronotherapeutics. Am J Cardiovasc Drugs. 2005;5:7–15.
 3. O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement 
D, de la Sierra A, de Leeuw P, Dolan E, et  al. European Society of 
Hypertension position paper on ambulatory blood pressure monitoring. 
J Hypertens. 2013;31:1731–1768.
 4. Hermida RC, Crespo JJ, Otero A, Dominguez-Sardina M, Moya A, Rios 
MT, Castineira MC, Callejas PA, Pousa L, Sineiro E, et al. Asleep blood 
pressure: significant prognostic marker of vascular risk and therapeutic 
target for prevention. Eur Heart J. 2018;39:4159–4171.
 5. Birkenhager AM, van den Meiracker AH. Causes and consequences of 
a non- dipping blood pressure profile. Neth J Med. 2007;65:127–131.
 6. Chen Y, Liu JH, Zhen Z, Zuo Y, Lin Q, Liu M, Zhao C, Wu M, Cao G, 
Wang R, et  al. Assessment of left ventricular function and peripheral 
vascular arterial stiffness in patients with dipper and non- dipper hyper-
tension. J Investig Med. 2018;66:319–324.
 7. Cuspidi C, Macca G, Sampieri L, Fusi V, Severgnini B, Michev I, Salerno 
M, Magrini F, Zanchetti A. Target organ damage and non- dipping pat-
tern defined by two sessions of ambulatory blood pressure monitoring 
in recently diagnosed essential hypertensive patients. J Hypertens. 
2001;19:1539–1545.
 8. Karadag B, Ozyigit T, Serindag Z, Ilhan A, Ozben B. Blood pressure 
profile is associated with microalbuminuria and retinopathy in hy-
pertensive nondiabetic patients. Wien Klin Wochenschr. 2018;130: 
204–210.
 9. Kilic A, Baydar O. The relationship between diurnal blood pressure ab-
normalities and target organ damage in normotensive subjects. Which 
is more important? Increased blood pressure levels or circadian blood 
pressure abnormalities. Clin Exp Hypertens. 2020;42:244–249.
 10. Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD, 
Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. Prognostic 
effect of the nocturnal blood pressure fall in hypertensive patients: the 
ambulatory blood pressure collaboration in patients with hypertension 
(ABC- H) meta- analysis. Hypertension. 2016;67:693–700.
 11. Yan B, Peng L, Dong Q, Zheng F, Yang P, Sun L, Gong S, Zeng L, 
Wang G. Reverse- dipper pattern of blood pressure may predict la-
cunar infarction in patients with essential hypertension. Eur J Neurol. 
2015;22:1022–1025.
 12. Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative 
effects of ramipril on ambulatory and office blood pressures: a HOPE 
Substudy. Hypertension. 2001;38:E28–E32.
 13. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of circadian 
time of hypertension treatment on cardiovascular risk: results of the 
MAPEC study. Chronobiol Int. 2010;27:1629–1651.
D
ow
nloaded from
 http://ahajournals.org by on June 11, 2020
J Am Heart Assoc. 2020;9:e016299. DOI: 10.1161/JAHA.119.016299 10
Chokesuwattanaskul et al Circadian Blood Pressure Pattern and CSVD
 14. Pantoni L. Cerebral small vessel disease: from pathogenesis and 
clinical characteristics to therapeutic challenges. Lancet Neurol. 
2010;9:689–701.
 15. Wardlaw JM, Chappell FM, Valdes Hernandez MDC, Makin SDJ, Staals 
J, Shuler K, Thrippleton MJ, Armitage PA, Munoz-Maniega S, Heye AK, 
et al. White matter hyperintensity reduction and outcomes after minor 
stroke. Neurology. 2017;89:1003–1010.
 16. Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms 
and clinical implications. Lancet Neurol. 2019;18:684–696.
 17. van Middelaar T, Argillander TE, Schreuder F, Deinum J, Richard E, 
Klijn CJM. Effect of antihypertensive medication on cerebral small 
vessel disease: a systematic review and meta- analysis. Stroke. 
2018;49:1531–1533.
 18. Sander D, Klingelhofer J. Diurnal systolic blood pressure variability 
is the strongest predictor of early carotid atherosclerosis. Neurology. 
1996;47:500–507.
 19. Moher D, Liberati A, Tetzlaff J, Altman DG; Group P. Preferred reporting 
items for systematic reviews and meta- analyses: the PRISMA state-
ment. J Clin Epidemiol. 2009;62:1006–1012.
 20. Stang A. Critical evaluation of the Newcastle- Ottawa scale for the as-
sessment of the quality of nonrandomized studies in meta- analyses. 
Eur J Epidemiol. 2010;25:603–605.
 21. DerSimonian R, Laird N. Meta- analysis in clinical trials. Control Clin 
Trials. 1986;7:177–188.
 22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsis-
tency in meta- analyses. BMJ. 2003;327:557–560.
 23. Hamada T, Murata T, Omori M, Takahashi T, Kosaka H, Wada Y, Yoshida 
H. Abnormal nocturnal blood pressure fall in senile- onset depres-
sion with subcortical silent cerebral infarction. Neuropsychobiology. 
2003;47:187–191.
 24. Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Ohara T, Ozasa K. The rela-
tionship between 24- hour blood pressure readings, subcortical ischemic 
lesions and vascular dementia. Cerebrovasc Dis. 2005;19:302–308.
 25. Henskens LH, van Oostenbrugge RJ, Kroon AA, de Leeuw PW, Lodder 
J. Brain microbleeds are associated with ambulatory blood pressure 
levels in a hypertensive population. Hypertension. 2008;51:62–68.
 26. Staals J, van Oostenbrugge RJ, Knottnerus IL, Rouhl RP, Henskens LH, 
Lodder J. Brain microbleeds relate to higher ambulatory blood pressure 
levels in first- ever lacunar stroke patients. Stroke. 2009;40:3264–3268.
 27. Ma JF, Sun JL, Zhao J, Wei X, Wang BS, Fu Y. Relationship between 
nocturnal blood pressure variation and silent cerebral infarction in 
Chinese hypertensive patients. J Neurol Sci. 2010;294:67–69.
 28. Yamamoto Y, Ohara T, Nagakane Y, Tanaka E, Morii F, Koizumi T, 
Akiguchi I. Chronic kidney disease, 24- h blood pressure and small ves-
sel diseases are independently associated with cognitive impairment in 
lacunar infarct patients. Hypertens Res. 2011;34:1276–1282.
 29. Shimizu M, Ishikawa J, Yano Y, Hoshide S, Shimada K, Kario K. The 
relationship between the morning blood pressure surge and low- 
grade inflammation on silent cerebral infarct and clinical stroke events. 
Atherosclerosis. 2011;219:316–321.
 30. Lee S, Thomas RJ, Kim H, Seo HS, Baik I, Yoon DW, Kim SJ, Lee SK, 
Shin C. Association between high nocturnal blood pressure and white 
matter change and its interaction by obstructive sleep apnoea among 
normotensive adults. J Hypertens. 2014;32:2005–2012; discussion 2012
 31. Kwon HM, Lim JS, Kim YS, Moon J, Park H, Kim HY, Lim YH, Nam H. 
Cerebral microbleeds are associated with nocturnal reverse dipping in 
hypertensive patients with ischemic stroke. BMC Neurol. 2014;14:8.
 32. Yamashiro K, Tanaka R, Shimo Y, Oyama G, Ogawa T, Umemura A, 
Hattori N. Cerebral microbleeds and blood pressure abnormalities in 
Parkinson’s disease. eNeurologicalSci. 2018;10:5–11.
 33. White WB, Jalil F, Wakefield DB, Kaplan RF, Bohannon RW, Hall CB, 
Moscufo N, Fellows D, Guttmann CRG, Wolfson L. Relationships 
among clinic, home, and ambulatory blood pressures with small vessel 
disease of the brain and functional status in older people with hyperten-
sion. Am Heart J. 2018;205:21–30.
 34. Nakanishi K, Jin Z, Homma S, Elkind MSV, Rundek T, Schwartz JE, 
Lee TC, Tugcu A, Yoshita M, DeCarli C, et al. Night- time systolic blood 
pressure and subclinical cerebrovascular disease: the Cardiovascular 
Abnormalities and Brain Lesions (CABL) study. Eur Heart J Cardiovasc 
Imaging. 2019;20:765–771.
 35. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic 
Reviews of Interventions Version 5.1.0 [updated March 2011]. The 
Cochrane Collaboration, 2011. Available at: www.handbook.cochrane.org.
 36. Redon J, Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita 
Fernandez S, Navarro-Perez J, Pallares V, Valls F, Fernandez A, Perez-
Navarro AM, et al. Impact of hypertension on mortality and cardiovas-
cular disease burden in patients with cardiovascular risk factors from 
a general practice setting: the ESCARVAL- risk study. J Hypertens. 
2016;34:1075–1083.
 37. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA; Group ISTC. 
Blood pressure and clinical outcomes in the International Stroke Trial. 
Stroke. 2002;33:1315–1320.
 38. Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, 
Meschia JF. CNS small vessel disease: a clinical review. Neurology. 
2019;92:1146–1156.
 39. Rizzoni D, Rizzoni M, Nardin M, Chiarini G, Agabiti-Rosei C, Aggiusti C, 
Paini A, Salvetti M, Muiesan ML. Vascular aging and disease of the small 
vessels. High Blood Press Cardiovasc Prev. 2019;26:183–189.
 40. Meissner A. Hypertension and the brain: a risk factor for more than 
heart disease. Cerebrovasc Dis. 2016;42:255–262.
 41. Ferrer I, Vidal N. Neuropathology of cerebrovascular diseases. Handb 
Clin Neurol. 2017;145:79–114.
 42. Baschieri F, Cortelli P. Circadian rhythms of cardiovascular autonomic 
function: physiology and clinical implications in neurodegenerative dis-
eases. Auton Neurosci. 2019;217:91–101.
 43. Crnko S, Du Pre BC, Sluijter JPG, Van Laake LW. Circadian rhythms 
and the molecular clock in cardiovascular biology and disease. Nat Rev 
Cardiol. 2019;16:437–447.
 44. Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi 
F. Dipper and non- dipper blood pressure 24- hour patterns: circadian 
rhythm- dependent physiologic and pathophysiologic mechanisms. 
Chronobiol Int. 2013;30:17–30.
 45. Cuspidi C, Tadic M, Sala C, Gherbesi E, Grassi G, Mancia G. Blood 
pressure non- dipping and obstructive sleep apnea syndrome: a meta- 
analysis. J Clin Med. 2019;8:E1367.
 46. Yan B, Peng L, Han D, Sun L, Dong Q, Yang P, Zheng F, Ong H, Zeng 
L, Wang G. Blood pressure reverse- dipping is associated with early 
formation of carotid plaque in senior hypertensive patients. Medicine 
(Baltimore). 2015;94:e604.
 47. Izzedine H, Launay-Vacher V, Deray G. Abnormal blood pressure circa-
dian rhythm: a target organ damage? Int J Cardiol. 2006;107:343–349.
 48. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, 
Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, et  al. 
Neuroimaging standards for research into small vessel disease and 
its contribution to ageing and neurodegeneration. Lancet Neurol. 
2013;12:822–838.
 49. Das AS, Regenhardt RW, Vernooij MW, Blacker D, Charidimou A, 
Viswanathan A. Asymptomatic cerebral small vessel disease: insights 
from population- based studies. J Stroke. 2019;21:121–138.
 50. Cheng AL, Batool S, McCreary CR, Lauzon ML, Frayne R, Goyal M, 
Smith EE. Susceptibility- weighted imaging is more reliable than T2*- 
weighted gradient- recalled echo MRI for detecting microbleeds. Stroke. 
2013;44:2782–2786.
 51. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Decreasing sleep- time 
blood pressure determined by ambulatory monitoring reduces cardio-
vascular risk. J Am Coll Cardiol. 2011;58:1165–1173.
 52. Smolensky MH, Hermida RC, Ayala DE, Mojon A, Fernandez JR. 
Bedtime chronotherapy with conventional hypertension medications 
to target increased asleep blood pressure results in markedly better 
chronoprevention of cardiovascular and other risks than customary on- 
awakening therapy. Heart Fail Clin. 2017;13:775–792.
 53. Investigators A-H, Roush GC, Fagard RH, Salles GF, Pierdomenico 
SD, Reboldi G, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia 
J, et al. Prognostic impact from clinic, daytime, and night- time systolic 
blood pressure in nine cohorts of 13,844 patients with hypertension. J 
Hypertens. 2014;32:2332–2340.
D
ow
nloaded from
 http://ahajournals.org by on June 11, 2020
SUPPLEMENTAL MATERIAL
D
ow
nloaded from
 http://ahajournals.org by on June 11, 2020
Data S1.
Supplemental Methods 
Search terms for systematic review (Databases: Ovid MEDLINE, Database: EMBASE, and 
Cochrane Database, N = 1334).  
Database: EMBASE  (1,288 articles) 
('non dipping' OR 'dipping' OR 'dipper' OR 'non dipper' OR 'non dipper hypertension' OR 
'reverse dipping' OR (circadian AND blood AND pressure) OR 'nocturnal blood pressure' OR 
'nocturnal blood pressure dipping' OR 'night-time blood pressure' OR 'blood pressure monitoring' 
OR 'ambulatory blood pressure' OR 'ambulatory blood pressure measurement') AND ('silent 
cerebrovascular disease' OR 'ischemic stroke' OR 'white matter hyperintensity' OR 'lacunar 
infarct' OR 'cerebral microbleed' OR 'brain microbleed' OR 'small vessel disease' OR 
'cerebrovascular disease' OR 'occlusive cerebrovascular disease' OR 'silent cerebral infarction' 
OR 'silent cerebral infarct' OR 'white matter change' OR 'perivascular space') 
Database: Ovid  MEDLINE  (46 articles) 
1     dipper.mp. 
2     dipping.mp. 
3     non dipper.mp. 
4     non dipping.mp. 
5     reverse-dipping.mp. 
6     reverse dipper.mp. 
7     circadian blood pressure.mp. 
8     nocturnal blood pressure.mp. 
9     night-time blood pressure.mp. 
10     ambulatory blood pressure.mp. 
11     ambulatory blood pressure monitoring.mp. 
12     1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 
13     silent cerebrovascular disease.mp. 
14     silent stroke.mp. 
15     silent ischemic stroke.mp. 
16     white matter hyperintensity.mp. 
17     lacunar infarct.mp. 
18     cerebral microbleed$.mp. 
19     brain microbleed$.mp. 
20     small vessel disease.mp. 
21     cerebrovascular disease.mp. 
22     silent cerebral infarct.mp. 
23     white matter change.mp. 
24    perivascular space$.mp. 
25     13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 
26     13 and 25 
D
ow
nloaded from
 http://ahajournals.org by on June 11, 2020
Cochrane Database  (0 articles) 
('non dipping' OR 'dipping' OR 'dipper' OR 'non dipper' OR 'non dipper hypertension' OR 
'reverse dipping' OR (circadian AND blood AND pressure) OR 'nocturnal blood pressure' OR 
'nocturnal blood pressure dipping' OR 'night-time blood pressure' OR 'blood pressure monitoring' 
OR 'ambulatory blood pressure' OR 'ambulatory blood pressure measurement') AND ('silent 
cerebrovascular disease' OR 'ischemic stroke' OR 'white matter hyperintensity' OR 'lacunar 
infarct' OR 'cerebral microbleed' OR 'brain microbleed' OR 'small vessel disease' OR 
'cerebrovascular disease' OR 'occlusive cerebrovascular disease' OR 'silent cerebral infarction' 
OR 'silent cerebral infarct' OR 'white matter change' OR 'perivascular space') 
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PRISMA 2009 Checklist 
Section/topic # Checklist item Reported on page # 
TITLE 
Title 1 Identify the report as a systematic review, meta-analysis, or both. Title 
ABSTRACT 
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
1 
INTRODUCTION 
Rationale 3 Describe the rationale for the review in the context of what is already known. 3 
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
4 
METHODS 
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
4 
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
4-5
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
4-5
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
4-5
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
5 
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators.  
4-5
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
5-6
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
5 
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). 5-6
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I2) for each meta-analysis.  
6 
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Section/topic # Checklist item Reported 
on page 
# 
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
5-6
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
6 
RESULTS 
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
6-7
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
Table 1 
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). Table 1 
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
Figure 2-
3 
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. 7-8
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15). 8 
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]). 7-8
DISCUSSION 
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers).  
9-12
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
12 
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research. 12 
FUNDING 
Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
13 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS 
Med 6(6): e1000097. doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org. 
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Figure S1. Forest plots of studies with confounder-adjusted analysis assessing association 
between a non-dipping pattern and WMH. A diamond data marker depicts the overall rate from 
included studies (square data markers) and 95%CI 
Figure S2. Forest plots of studies with confounder-adjusted analysis assessing association 
between a non-dipping pattern and ALI. A diamond data marker depicts the overall rate 
from included studies (square data markers) and 95%CI 
Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper Relative 
ratio limit limit Z-Value p-Value weight
Nakanishi et al 1.620 1.101 2.383 2.450 0.014 34.80
Lee et al 1.030 0.788 1.346 0.216 0.829 42.70
Yamamoto et al (1) 2.700 1.032 7.064 2.024 0.043 12.16
Yamamoto et al (2) 1.250 0.431 3.627 0.411 0.681 10.34
1.383 0.945 2.024 1.669 0.095
0.01 0.1 1 10 100
No WMH WMH
Meta Analysis
Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper Relative 
ratio limit limit Z-Value p-Value weight
Nakanishi et al 1.310 0.823 2.086 1.137 0.255 71.09
Yamamoto et al (1) 1.570 0.722 3.412 1.139 0.255 25.56
Yamamoto et al (2) 5.060 0.591 43.303 1.480 0.139 3.34
1.435 0.970 2.125 1.805 0.071
0.01 0.1 1 10 100
No ALI ALI
Meta Analysis
34 
30
24 
28 
34 
24 
28 
D
ow
nloaded from
 http://ahajournals.org by on June 11, 2020
Figure S3. Forest plots of studies with confounder-adjusted analysis assessing association 
between a non-dipping pattern and CMB. A diamond data marker depicts the overall rate 
from included studies (square data markers) and 95%CI 
Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper Relative 
ratio limit limit Z-Value p-Value weight
Henskens et al 1.430 0.378 5.411 0.527 0.598 7.70
Staals et al 1.070 0.692 1.655 0.304 0.761 71.71
Kwon et al 1.280 0.567 2.887 0.595 0.552 20.60
1.135 0.785 1.642 0.674 0.501
0.01 0.1 1 10 100
No CMB CMB
Meta Analysis
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26 
31 
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